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Analysis of 163 putativeShigella isolates fromCanada and the USA showed biochemical reactions
consistentwithShigella species, although none of the isolates reactedwith antiserum raised against
any of the well-established or provisional Shigella serotypes. All these isolates, provisionally
designated serotype SH108, were positive for the ipaH gene and the invasion-associated locus. All
fermentedmannitol, were serologically indistinguishable from each other and showed no reaction in
antisera prepared againstEscherichia coli serotypesO1 toO181. PCR-RFLP analysis of the genes
involved in O-antigen synthesis revealed a common pattern among these isolates that was distinct
from recognized Shigella serotypes and E. coli. Between 1999 and 2003, isolates from across
Canadawere submitted to theNational Laboratory for Enteric Pathogens for antibiotic susceptibility
testing, phage typing and PFGE. These assays revealed heterogeneity among the members of this
serotype. Antimicrobial susceptibility testing with seven antibiotics identified six profiles, with 90%
(45/50) of the isolates resistant to four ormore antibiotics and72% (36/50) resistant to five ormore.
All isolates were typable using a panel of 16 phages, with 11 different phage types (PTs)
represented. Themost commonPTs foundwere PT3 (64%), PT6 (10%) andPT16 (6%). Analysis
of XbaI-restricted genomic DNA revealed 16 highly related patterns that were not readily
distinguishable from those obtained for some other Shigella serotypes. The World Health
Organization Collaborating Center for Shigella has added serotype SH108 to the Shigella scheme
as S. boydii serotype 20 (serovar nov.). Strain SH108 (isolate 99-4528) is the reference strain for
this serotype.
INTRODUCTION
Infections with Shigella species cause approximately 600 000
deaths worldwide annually. Two-thirds of all cases and most
of the deaths occur among children under 10 years of age
(Chin, 2000). Although more prevalent in developing
countries, shigellosis is a worldwide problem. Transmission
of the disease is primarily by person-to-person contact
through contaminated hands (Butler, 2000). Outbreaks
typically occur under conditions involving close physical
contact, such as those encountered in day-care centres,
nursing homes, custodial institutions, cruise ships, aborigi-
nal reservations and crowded refugee camps, with poor
hygiene practices and contaminated food or water serving
as the vehicle for infection (Brian et al., 1993; Chin, 2000;
Edwards, 1999; Janda & Abbott, 1998). The infectious dose of
Shigella species is low, with 10–100 bacteria sufficient to
cause disease (International Commission on MicrobiologicalAbbreviation: PT, phage type.
Specifications for Foods, 1996; Trevejo et al., 1999; WHO
Scientific Working Group, 1980).
Shigellosis is an acute infectious bacterial disease causing
inflammatory enteritis in humans. Clinical manifestations of
classical bacillary dysentery include fever, vomiting, abdom-
inal pain, tenesmus (painful straining to pass stools) and
stools containing blood and mucus resulting from invasion
of the intestinal mucosa by the pathogen (Edwards, 1999;
Janda & Abbott, 1998; Keusch & Bennish, 1998; Keusch,
1998). Despite this, however, many cases present with only a
watery diarrhoea (Chin, 2000; Wathen-Grady et al., 1985).
Shigellae are host-adapted to the human intestine (Janda &
Abbott, 1998). Illness is usually self-limited and lasts an
average of 4–7 days, while the severity of illness and the case-
fatality rate are functions of the age and pre-existing
nutritional state of the host, as well as of the serotype of
bacteria causing disease (Chin, 2000).
The genus Shigella is divided into four subgroups that for
medical purposes continue to be treated as species: subgroup
A (Shigella dysenteriae), subgroup B (Shigella flexneri),
subgroup C (Shigella boydii), and subgroup D (Shigella
sonnei) (Bopp et al., 2003; Chin, 2000). S. flexneri, S. boydii
and S. dysenteriae account for most cases of human disease in
developing countries, whereas S. sonnei is more commonly
isolated in developed countries (Janda & Abbott, 1998).
S. boydii is relatively rare in developed countries and is
typically associated with individuals who have travelled to
endemic areas.
S. boydii isolates can be difficult to distinguish from S. flexneri
and enteroinvasive Escherichia coli. Isolates of this organism
differ mainly in that they are typically agglutinated by
S. boydii polyvalent group C antiserum and the correspond-
ing monovalent factor antisera specific for serotypes 1–19.
They are also differentiated by a recently described rfb RFLP
technique (Coimbra et al., 1999, 2001) that has proved to be
an effective molecular method for rapid characterization of
known Shigella O serotypes and for the detection of new
Shigella O serotypes.
In 1999, the National Laboratory for Enteric Pathogens
(NLEP) in Winnipeg, Canada, received eight lactose-non-
fermenting, D-mannitol-fermenting Shigella isolates bio-
chemically resembling S. flexneri. These isolates did not
agglutinate in antisera specific for the group or type antigens
of S. flexneri nor in antisera reactive with other recognized
and provisional serotypes of Shigella. They also lacked the
PCR-RFLP patterns characteristic of the molecular serotypes
of the recognized Shigella serotypes (Coimbra et al., 1999).
We have presented here laboratory and epidemiological
findings on a collection of clinical isolates received in Canada
and the USA that represent a newly emerging serotype of
S. boydii designated S. boydii serotype 20 by the Centers for
Disease Control and Prevention (CDC) in Atlanta.
METHODS
Strains. The S. boydii isolates that were characterized in this study were
submitted, along with any associated information about the cases from
which they were derived, by provincial Public Health Laboratories
across Canada and state public health laboratories across the USA for
confirmation of identification and serotyping results (Table 1; Demczuk
et al., 2001; Kalluri et al., 2004). Isolates were routinely grown on
nutrient agar and stored at 80 8C in either double-strength skimmed
milk or trypticase soy broth containing 10 % glycerol. Isolate 99-4528,
designated the S. boydii serotype 20 reference strain by the CDC, was
used as a control for all tests. Strain 99-4528 has been submitted to the
American Type Culture Collection (ATCC) and will be made available
to others in the scientific community.
Biochemical tests and serotyping. S. boydii is typically non-motile,
oxidase negative and catalase positive. Indole is variable, the methyl red
test is positive, Voges–Proskauer and Simmons’ citrate reactions are
negative, and lysine decarboxylase, arginine dihydrolase and ornithine
decarboxylase tests are negative. H2S is not produced, urea is not
hydrolysed and there is no growth in KCN broth. Carbohydrates are
usually fermented and these include glucose (in the absence of gas
production), D-mannitol, arabinose, trehalose and mannose (Holt et
al., 1994). The biochemical reactions of the isolates were determined
using the methods of Edwards and Ewing (Bopp et al., 2003; Ewing,
1986). Serological identification was performed by slide agglutination
with polyvalent, somatic (O) antigen grouping sera, followed by testing
Table 1. Distribution of isolates of S. boydii serotype 20 in Canadian provinces
(1999–2003)
BC, British Columbia; AB, Alberta; MB, Manitoba; ON, Ontario; QC, Quebec; NB, New
Brunswick; NS, Nova Scotia. ND, None detected.
Year No. of isolates
BC AB MB ON QC NB NS Total
1999 3 1 ND 2 2 ND ND 8
2000 3 ND ND 3 5 ND ND 11
2001 9 5 2 6 2 1 ND 25
2002 3 1 ND 1 ND ND 1 6
2003 4 1 ND ND ND ND ND 5
Total 22 8 2 12 9 1 1 55
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with monovalent antisera for specific serotype identification (Bopp et
al., 2003; Ewing, 1986).
Phage typing. Bacteriophages were isolated from municipal raw
sewage samples. Phage isolation, propagation, purification and typing
were conducted using standard methods (Adams, 1959; Ahmed et al.,
1987; Anderson & Williams, 1956). A phage typing scheme was
developed for S. boydii using 16 phages that were selected on the basis
of distinct lytic reactions.
R-typing.Antimicrobial resistance patterns (R-types) were determined
using BBL Sensi-Disc antimicrobial susceptibility discs (Becton Dick-
inson) according to procedures previously outlined by Bauer et al.
(1966) and the NCCLS (2001). Antibiotics used in this study included
ampicillin (10 g), chloramphenicol (30 g), ciprofloxacin (10 g),
streptomycin (10 g), sulfadiazine (0.25 g), tetracycline (30 g) and
trimethoprim/sulfamethoxazole (1.25/23.75 g).
PCR tests. Isolates were tested for the presence of the ipaH gene and for
the invasion-associated locus diagnostic for Shigella and enteroinvasive
E. coli as described by Sethabutr et al. (1993). PCR was used to
demonstrate the presence or absence of stx genes and was performed
according to the methods described by Paton & Paton (1997).
PFGE. PFGE was done according to previously described protocols
(CDC, 2000; Gautom, 1997). The S. sonnei F2353 standard strain was
used as the size marker. Briefly, bacteria were grown overnight in brain–
heart infusion broth, washed in cell suspension buffer (100 mM Tris/
HCl pH 8.0, 100 mM EDTA) and suspended in the same buffer to give a
density reading of approximately 0.50 in a Dade turbidity meter (Baxter
Diagnostics). Proteinase K (Roche Molecular Biochemicals) was added
to washed cells to a concentration of 1 mg ml1. Bacteria were then
directly embedded in an equal volume of 1.2 % SeaKem Gold agarose
(Mandel Scientific) and prepared using TE buffer (10 mM Tris/HCl pH
8.0, 1 mM EDTA) containing 1 % SDS. Solidified plugs were transferred
to 1.5 ml cell lysis buffer (50 mM Tris/HCl pH 8.0, 50 mM EDTA, 1 %
Sarkosyl, 0.1 mg proteinase K ml1) and incubated at 54 8C in a water
bath with shaking at 200 r.p.m. for 2 h. Plugs were washed twice at 50 8C
with distilled water (18 M quality) and three times for 15 min with TE.
All washes were in water baths with shaking as outlined above. Plug
slices were equilibrated in 100 l buffer H (Roche Molecular Biochem-
icals) at 37 8C for 15 min and digested at 37 8C for 2 h with 50 U XbaI in
200 l fresh buffer H. After digestion, plugs were equilibrated in 0.53
TBE (0.89 M Tris/HCl, 0.89 M boric acid, 0.02 M disodium EDTA, pH
8.4; Roche Molecular Biochemicals) in 1 % SeaKem Gold agarose at
14 8C. Initial and final switch times were 2.2 and 54.2 s, respectively, and
the total run time was 22 h. Following electrophoresis, gels were stained
with ethidium bromide (0.5 g ml1) and imaged using the GelDoc
1000 system (Bio-Rad).
Molecular serotyping. Molecular serotyping was done according to
previously published protocols with minor changes (Coimbra et al.,
1999, 2001). Bacteria were grown at 37 8C for 14–18 h on nutrient agar
containing 1.5 % NaCl. Bacteria were embedded in low-melting-point
agarose, lysed and washed according to the CDC PulseNet protocol for
this organism (CDC, 2000) as outlined for PFGE (above). Each agarose
plug was melted at 67 8C for 15 min in 500 l TE buffer and 5 l volumes
were used for long PCR. The PCR primers 482 and 412, complementary
to JUMPstart and gnd, were used with cycling conditions as previously
described (Coimbra et al., 1999). Amplicons were separated by gel
electrophoresis in 0.75 % agarose gels using DNA Molecular Weight
Marker III (Roche Diagnostics) to aid product size estimation. Between
8 and 20 l of product was digested for 2 h at 37 8C with 10 U MboII
restriction enzyme (New England Biolabs), followed by denaturation of
the enzyme for 10 min at 72 8C. Digested samples were fractionated for
5 h at 140 V (constant voltage) in 2 % agarose gels made with 50 %
typing-grade agarose and 50 % Agarose 1000 (Invitrogen Life Technol-
ogies) using a 1 kb PlusDNA Ladder (Invitrogen Life Technologies) to
allow gel normalization. RFLP patterns were normalized and analysed as
outlined below using Bionumerics 2.1 software (Applied Maths). These
patterns were compared with a library created in-house using all E. coli
and Shigella serotype reference strains, as well as any additional isolates
serotyped at the National Microbiology Laboratory (NML), Canada,
using reference and molecular serotyping techniques.
Sequencing. Sequencing of the 16S rRNA gene was performed as
described by Edwards et al. (1989), using an ABI 3100 gene analyser
(Applied Biosystems).
Analysis of data. Interpretation of the PFGE patterns was aided by the
Bionumerics version 2.1 software. All associations obtained using this
software package were checked visually by at least two laboratory staff
familiar with PFGE interpretation. For the isolates analysed in this
study, each unique pattern was given a separate designation. Similarity
coefficients were obtained within Bionumerics by calculating Dice
coefficients. Automated cluster analysis was performed within Bionu-
merics using the unweighted pair group method with arithmetic means
(UPGMA) as a way of organizing banding patterns for visual compari-
son. Band position tolerances and optimization values of 1 % were used
throughout. All pattern matches were confirmed visually.
RESULTS
From 1999 to 2003, a total of 55 laboratory-confirmed cases
of S. boydii serotype 20 infection were reported in seven
Canadian provinces (Table 1). No seasonality was observed
in the isolation or in the incidence of disease caused by these
organisms. Infection with S. boydii serotype 20 was associated
with recent travel to Cuba, Ethiopia, India, Guatemala and
Mexico. S. boydii infections in Canada showed a steady
increase between 1999 and 2000 (Table 1). Surveillance data
indicated that in 1999 S. boydii serotype 20 represented 18 %
of laboratory-confirmed cases of S. boydii infection in
Canada. By the year 2000, serotype 20 was the most frequent
causative agent (26 %) of S. boydii infections in Canada.
Phenotypic characterization of S. boydii serotype
20
S. boydii reference strain 99-4528 appeared microscopically
as Gram-negative straight rods. The biochemical reactions of
serotype 20 strains are typical of those observed for other
S. boydii serotypes (Table 2). Laboratory findings from
reciprocal agglutination studies showed that the O antigen
of strain 99-4528 was unique. This strain showed no
agglutination in antisera prepared against the established
and provisional serotypes of Shigella or in antisera specific for
E. coli antigens O1 to O181. Of the various recognized
Shigella serotypes and provisional serotypes, only the refer-
ence strain for S. boydii serotype 6 agglutinated in antiserum
prepared against the O antigen of reference strain 99-4528 of
S. boydii serotype 20. Adsorption of this antiserum with the
reference strain to S. boydii serotype 6 was required to ensure
the specificity of the S. boydii serotype 20 antiserum.
The S. boydiiphage typing scheme was capable of subdividing
isolates from well-characterized serotypes. There was a wide
distribution of phage types (PTs) in reference strains
Shigella boydii 20 serovar nov.
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belonging to S. boydii serotypes 1–19. The 50 S. boydii
serotype 20 isolates were subdivided into 11 different PTs and
none of the isolates tested was untypable. The most common
PT, representing 64 % of S. boydii 20 isolates, was PT 3
(Table 3).
Of the 50 S. boydii serotype 20 isolates investigated using
antimicrobial susceptibility testing, 45 (90 %) were resistant
to more than four antibiotics (Table 4). Two isolates were
resistant to six of the antibiotics tested and belonged to PT 5.
The association between antibiotic R-type, PT, PFGE pattern
and the country of travel for isolates from individuals with
travel-associated disease is outlined in Table 5.
Genotyping and subtyping
All the isolates tested carried the ipaH gene and invasion-
associated locus, but did not carry any detectable stx genes.
Sequencing of the 16S rRNA gene locus indicated that the
S. boydii serotype 20 type strain was closely related to S. boydii
ATCC 9207 (data not shown). Molecular serotyping through
RFLP analysis of the locus responsible for O-antigen bio-
synthesis indicated that serotype 20 could be distinguished
from serotypes 1–19 (Fig. 1). PFGE analysis using XbaI was
performed on all S. boydii serotype 20 isolates and individual
reference isolates of S. boydii serotypes 1–19. The resulting
PFGE patterns were compared (Fig. 2) with XbaI PFGE
patterns of a small number of S. sonnei and S. flexneri
randomly selected from the PulseNet Canada Shigella PFGE
database to determine whether PFGE would be a valuable
tool for: (i) differentiating among serotypes; and (ii) differ-
entiating among strains within serotype 20.
The collection of 50 serotype 20 isolates was divided into 16
distinctXbaI patterns that differed by only a few minor bands
against a relatively conserved band arrangement. All serotype
20 isolates showed greater than 90 % pattern similarity to
each other, although there appeared to be sufficient pattern
variability within even this small population to make PFGE
using XbaI useful for confirmation of traceback investiga-
tions, disease surveillance and detection of case clusters that
may be outbreaks. With the exception of serotypes 1, 18 and
19, serotype 20 isolates were less than 85 % similar to the
other S. boydii serotypes. PFGE patterns of the S. boydii
serotype 20 isolates clustered more closely with PFGE
fingerprints from some S. sonnei isolates than with isolates
from other S. boydii serotypes, indicating that the clustering
of PFGE patterns in this population does not reflect
phylogenetic relationships. S. flexneri PFGE fingerprints also
clustered among the S. boydii and S. sonnei patterns; the
isolate showing the greatest PFGE pattern difference was
Table 2. Biochemical reactions of S. boydii serotype 20 refer-
ence strain SH108 (99-4528)
TSI, Triple-sugar iron; V, variable.
Test Reaction
H2S (TSI) 
Urease 
Indole V
Methyl red (37 8C) +
Voges–Proskauer (37 8C) 
Simmons’ citrate 
Christensen’s citrate 
Sodium acetate 
Sodium malonate 
Mucate 
KCN 
Motility 
Lysine decarboxylase 
Arginine dihydrolase 
Ornithine decarboxylase 
Phenylalanine deaminase 
-Galactosidase (ONPG) 
Catalase +
Oxidase 
Glucose (acid) +
Glucose (gas) 
Lactose 
Sucrose 
Mannitol +
Dulcitol 
Salicin 
Adonitol 
Inositol 
Sorbitol +
Arabinose +
Raffinose 
Rhamnose 
Maltose 
Xylose +
Trehalose +
Cellobiose 
Mannose +
Glycerol +
Esculin 
Table 3. PT distribution of S. boydii serotype 20 isolates in
Canada (1999–2002)
PT No. of isolates Percentage
1 1 2
2 2 4
3 32 64
5 2 4
6 5 10
8 1 2
10 1 2
11 1 2
14 1 2
16 3 6
17 1 2
Total 50 100
D. L. Woodward and others
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S. boydii serotype 13 (Fig. 2). Because S. boydii isolates of
serotypes other than 20 have either been rarely associated
with human disease in Canada or have not been referred to
our reference laboratory for more complete characterization,
it was not possible to determine whether the PFGE patterns
of the isolates used in this study were characteristic of each
serotype as a whole.
DISCUSSION
Serological identification is a crucial step in the diagnosis of
Shigella infections (Coimbra et al., 2001). In 1985, S. boydii
consisted of a total of 18 serotypes after the addition of three
new serotypes, S. boydii serotypes 16, 17 and 18 (Gross et al.,
1980; Wathen-Grady et al., 1985). Serotype 19, represented
Table 4. Antibiotic resistance profiles of S. boydii serotype 20 isolates with corresponding PTs
A, ampicillin; C, chloramphenicol; Ci, ciprofloxacin; S, streptomycin; Su, sulfadiazine; T, tetracycline; Tm, trimethoprim/sulfamethoxazole.
Antibiogram No. of isolates PTs represented
ACSSuTTm 2 PT 5 (2)
ASSuTTm 34 PT 1 (1), PT 2 (1), PT 3 (22), PT 6 (4), PT 8 (1), PT 11 (1), PT 14 (1), PT 16 (2), PT 17(1)
SsuTTm 9 PT 3 (9)
SsuTm 3 PT 2 (1), PT 3 (1), PT 10 (1)
ACST 1 PT 6 (1)
CT 1 PT 16 (1)
Table 5. Antibiotic resistance profiles, PTs and PGFE profiles of S. boydii serotype 20 isolates associated with travel
Year No. of cases Province* Country of travel R-type† PT PFGE pattern‡
2002 1 BC Guatemala Sensitive 3 SBXAI.0037
2002 1 BC Guatemala Sensitive 3 SBXAI.0038
2001 1 AB India ST 4 SBXAI.0016
2001 1 AB India SsuTTm 4 SBXAI.0009
2001 1 MB Ethiopia ASSuTTm 4 SBXAI.0011
2001 1 QB Mexico SSuTTm 4 SBXAI.0017
2002 1 NS Cuba ASSuTTm 3 SBXAI.0038
*For definitions, see Table 1.
†For definitions, see Table 4.
‡SBXAI, S. boydii restricted with XbaI.
Fig. 1. O-antigen molecular serotyping patterns produced by PCR-RFLP.
Shigella boydii 20 serovar nov.
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Fig. 2. Dendrogram showing the PFGE patterns of S. boydii serotype 20 isolates compared with other Shigella serotypes. The
dendrogram was constructed with Bionumerics 2.1 software using the unweighted pair group method with arithmetic means
(UPGMA) method. Thin lines were added by the program and show the location (peak of densitometry curve) of less-intense bands
included in the analysis.
D. L. Woodward and others
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by strain E16553 and first described in 1982, was recently
added to the scheme (Gross et al., 1982).
S. boydii represents less than 1–2 % of the total Shigella
isolated, except in the Indian subcontinent (Keusch &
Bennish, 1998). In 1999, the NLEP in Canada identified
what appeared to be a new emerging serotype of S. boydii.
Epidemiological data identified seven cases that have been
directly associated with travel to Cuba, Ethiopia, Guatemala,
India and Mexico. While the other cases were not directly
linked to travel outside Canada, the low prevalence of
S. boydii endemic to this country suggests that they, too,
might be travel associated. Cases of shigellosis associated
with travel to Mexico and products exported from Mexico
have been well documented (Crowe et al., 1999). Outbreaks
of S. sonnei infection in the USA and Canada in 1998 were
associated with parsley imported from Mexico (Crowe et al.,
1999).
Between 2000 and 2003, the CDC received 108 isolates of
S. boydii serotype 20 from 23 different states across the USA.
An outbreak in California in 2001 was associated with 45
cases. At least 12 of the 45 S. boydii serotype 20 cases
associated with this outbreak were associated with travel to
Mexico (Kalluri et al., 2004). As in Canada, the prevalence of
cases associated with this serotype has increased dramatically
in the USA. The epidemiology of this organism in the USA
has recently been described by Kalluri et al. (2004).
The S. boydii phage typing scheme developed at the NML
provided additional discrimination among S. boydii strains.
PTs appeared to vary independently of serotype. Thus, while
PT 3 was characteristic of a majority (64 %) of serotype 20
isolates, it was also found in the reference serotype 19 strain.
Both PT and serotype could be used to obtain greater
discrimination among strains.
Resistance to antimicrobial agents commonly used in the
treatment of shigellosis is a continuing major problem in
both developed and developing countries (Keusch & Ben-
nish, 1998). Shigella resistant to multiple antibiotics has
appeared in all areas of the world, a phenomenon related to
the widespread use of antimicrobial reagents (Chin, 2000). In
this study high levels of resistance were observed, with 45
(90 %) of the 50 isolates of S. boydii serotype 20 tested being
resistant to four or more of the seven antibiotics used (Table
4). It has been estimated that 93.5 % of Shigella isolates
associated with travel to developing nations are resistant to at
least one antibiotic (Janda & Abbott, 1998), suggesting that
most strains expressing multi-drug resistance may be asso-
ciated with travel.
It is difficult to assess whether the overall PFGE pattern
similarity of the S. boydii serotype 20 isolates is characteristic
of the serotype as a whole or whether it results from isolates
representative of a widely circulating dominant clonal type
present in Canada at the time. XbaI PFGE fingerprints of
serotypes 1, 18 and 19 were similar to those of serotype 20
strains. PFGE patterns from most serotypes exhibited simi-
larities of 85 % or less, suggesting that the larger population
of S. boydii strains is less homogeneous than the serotype 20
strains studied to date. However, only a few strains have so far
been included in the S. boydii database and further study is
required to validate these observations. Little is known about
the population structure of S. boydii as a whole or how
organisms vary with their place of origin. However, it is clear
that XbaI PFGE pattern diversity within S. boydii is adequate
for effective subtyping of strains.
The Shigella isolates described here, represented by the
reference strain 99-4528, have been characterized using
various phenotypic and genotypic epidemiological markers.
Based on the identification procedures used, these strains
have been designated S. boydii 20.
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